Unusual Machines, Inc.
For the period ended Sep 30, 2025. Filed Nov 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 6, 2025
UMAC$13.48+13.3%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Condensed Balance Sheets
| September 30, 2025 | December 31, 2024 | |
|---|---|---|
| (Unaudited) | ||
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $64,285,750 | $3,757,323 |
| Short-term investments | 16,849,713 | – |
| Accounts receivable | 309,544 | 66,575 |
| Inventories | 3,118,491 | 1,335,503 |
| Prepaid inventory | 6,921,679 | 904,728 |
| Other current assets | 218,871 | 31,500 |
| Total current assets | 91,704,048 | 6,095,629 |
| Non-current assets: | ||
| Property and equipment, net | 1,728,661 | 570 |
| Operating lease right-of-use asset, net | 1,268,278 | 323,514 |
| Other assets | 84,693 | 59,426 |
| Goodwill | 7,402,906 | 7,402,906 |
| Intangible assets, net | 2,164,264 | 2,225,530 |
| Unallocated purchase price provisional, Rotor Lab (See note 3) | 8,725,968 | – |
| Total non-current assets | 21,374,770 | 10,011,946 |
| Total assets | $113,078,818 | $16,107,575 |
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||
| Current liabilities | ||
| Accounts payable and accrued expenses | $1,167,242 | $668,732 |
| Operating lease liability | 247,957 | 67,820 |
| Deferred revenue | 1,518,736 | 197,117 |
| Contingent consideration | 3,000,000 | – |
| Total current liabilities | 5,933,935 | 933,669 |
| Non-current liabilities | ||
| Deferred tax liability | 93,793 | 93,793 |
| Operating lease liability – non-current | 1,035,175 | 262,171 |
| Total non-current liabilities | 1,128,968 | 355,964 |
| Total liabilities | 7,062,903 | 1,289,633 |
| Commitments and contingencies (See note 13) | – | – |
| Stockholders’ equity: | ||
| Preferred stock - $0.01 par value, 10,000,000 authorized (See note 10) | – | – |
| Series A preferred stock - $0.01 par value, 4,250 designated and 0 and 0 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively | – | – |
| Series B preferred stock - $0.01 par value, 1,000 designated and 0 and 0 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively | – | – |
| Series C preferred stock - $0.01 par value, 3,000 designated and 0 and 0 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively | – | – |
| Common stock - $0.01 par value, 500,000,000 authorized and 31,568,949 and 15,122,018 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively | 315,688 | 151,221 |
| Additional paid in capital | 150,239,016 | 50,580,235 |
| Accumulated deficit | (44,541,067) | (35,913,514) |
| Cumulative foreign currency translation adjustment | 2,278 | – |
| Total stockholders’ equity | 106,015,915 | 14,817,942 |
| Total liabilities and stockholders’ equity | $113,078,818 | $16,107,575 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.